ÂÜÀòÂÒÂ×

Clinton Musil has a strong background in finance and corporate development. Clinton is currently serving as the Chief Financial Officer at Skyhawk Therapeutics. Prior to this, they held the same role at Catalyst Biosciences from June 2020 to September 2021. Clinton also worked as the Chief Business Officer at Personalis, Inc. from 2018 to June 2020. Clinton has experience in corporate development and investment banking, having served as the Vice President of Corporate Development at ARMO BioSciences from 2017 to July 2018. Clinton also worked at Deutsche Bank and Wells Fargo Securities in healthcare investment banking roles. Additionally, they worked as a Vice President at Essex Woodlands and as an Associate at Sanofi. Clinton Musil began their career at Needham & Company, where they served as an Analyst and Associate in healthcare investment banking.

Clinton Musil completed their Bachelor of Science (BS) degree in Molecular and Cellular Biology from the University of Arizona from 1999 to 2003. Clinton then pursued further education and earned a Master of Business Administration (MBA) degree from Harvard Business School between 2008 and 2010.